Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Cash from Investing Activities (2021 - 2025)

Prime Medicine filings provide 5 years of Cash from Investing Activities readings, the most recent being $28.3 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 41.29% to $28.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$108.8 million, a 258.88% decrease, with the full-year FY2025 number at -$108.8 million, down 258.88% from a year prior.
  • Cash from Investing Activities hit $28.3 million in Q4 2025 for Prime Medicine, up from -$92.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $50.3 million in Q3 2024 to a low of -$92.1 million in Q3 2025.
  • Median Cash from Investing Activities over the past 5 years was $2.8 million (2025), compared with a mean of -$3.3 million.
  • Biggest five-year swings in Cash from Investing Activities: soared 401.64% in 2023 and later plummeted 282.99% in 2025.
  • Prime Medicine's Cash from Investing Activities stood at $12.2 million in 2021, then tumbled by 212.61% to -$13.7 million in 2022, then soared by 401.64% to $41.3 million in 2023, then rose by 16.88% to $48.3 million in 2024, then plummeted by 41.29% to $28.3 million in 2025.
  • The last three reported values for Cash from Investing Activities were $28.3 million (Q4 2025), -$92.1 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.